Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2022 - 05 - 19 save search
Adverum Biotechnologies Presents Research Pipeline Data Supporting Utility of its Proprietary Platform and AAV.7m8 Capsid in Ocular Gene Therapy
Published: 2022-05-19 (Crawled : 20:00) - biospace.com/
ADVM | News | $10.96 -3.35% -3.47% 310K
|
Health Technology
|
| O: 2.6%
H: 0.57%
C: -0.08%
research ocular therapy platform
Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Published: 2022-05-19 (Crawled : 14:00) - biospace.com/
ALLO | $3.365 -1.03% -1.04% 1.6M
|
Health Technology
|
| O: -0.14%
H: 5.03%
C: 3.99%
pre-clinical therapeutics presentation therapy preclinical
RenovoRx to Present Preclinical Research Data Demonstrating its Innovative Therapy Platform’s Potential Utility for the Treatment of Bile Duct Cancer
Published: 2022-05-19 (Crawled : 14:00) - biospace.com/
RNXT | $1.23 4.88% 2.8K
|
|
| O: 2.39%
H: 0.0%
C: -14.02%
treatment research preclinical potential therapy cancer pre-clinical
RenovoRx Announces Preclinical Research Data Demonstrating its Innovative Therapy Platform’s Potential Utility for the Treatment of Bile Duct Cancer
Published: 2022-05-19 (Crawled : 13:00) - renovorx.com
RNXT | $1.23 4.88% 2.8K
|
|
| O: 2.39%
H: 0.0%
C: -14.02%
treatment research preclinical potential therapy cancer pre-clinical
Mustang Bio Announces Updated Interim Data on X-Linked Severe Combined Immunodeficiency Treatment with Lentiviral Vector Gene Therapy Support Upcoming Multicenter Pivotal Phase 2 Trial for MB-107
Published: 2022-05-19 (Crawled : 13:00) - globenewswire.com
MBIO | $0.3355 -1.32% -1.34% 120K
|
Health Technology
|
| O: -2.74%
H: 2.9%
C: -0.53%
FBIO | $1.79 2.29% 2.23% 190K
|
Health Technology
|
| O: -2.64%
H: 11.49%
C: 5.69%
mb-107 treatment trial therapy phase 2
TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-19 (Crawled : 12:00) - biospace.com/
TCRX | News 3 d | $7.23 1.55% 1.52% 210K
|
Professional, Scientific, and T...
|
| O: 1.15%
H: 1.42%
C: -13.35%
preclinical therapeutics therapy pre-clinical
Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-19 (Crawled : 12:00) - biospace.com/
AKUS | $13.29 1.07% 3.46%
|
Health Technology
|
| O: -3.3%
H: 0.68%
C: -3.41%
therapy
Voyager Therapeutics’ TRACER™ Capsids Demonstrate Enhanced CNS Transduction Across Species; New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
Published: 2022-05-19 (Crawled : 12:00) - biospace.com/
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: -1.86%
H: 3.8%
C: 0.95%
preclinical als therapy results pre-clinical
Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2022-05-19 (Crawled : 12:00) - biospace.com/
RCKT 4 | $23.705 -0.69% -0.7% 450K
|
Health Technology
|
| O: -1.95%
H: 5.37%
C: -0.5%
program positive therapy topline
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.